National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
In English | En español
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
 Display for Print  New Search
 
Results: 1 -6 of 6         results per page
 View Search Criteria | Help With Results
           

1.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase III
Treatment
Active
18 and over
Pharmaceutical / Industry
D4320C00015
NCT00626548


2.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II
Treatment
Active
18 and over
Other
2006-01
NCT00420563

Last Modified: 9/18/2008     First Published: 7/13/2007  

3.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II
Biomarker/Laboratory analysis, Treatment
Active
18 and over
NCI
GOG-0224
GOG-0224, NCT00503581


4.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II
Treatment
Active
18 and over
Other
06-685
Version April 9, 2007, NCT00483327

Last Modified: 9/8/2008     First Published: 8/5/2008  

5.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II
Treatment
Approved-not yet active
Not specified
NCI
GOG-0248
GOG-0248, NCT00729586


6.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

No phase specified
Supportive care
Active
Under 18
Other
H06-03499
CW06- 0294, NCT00439101

   
  Display for Print   New Search

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov